← FDA Drug Approvals (Drugs@FDA)
XOPENEX HFA
NDA · New Drug Application · Sponsor: LUPIN · Approved 2005-03-11
Drug application
- FDA Application #
NDA021730- Application type
- New Drug Application
- Brand name
- XOPENEX HFA
- Generic name
- LEVALBUTEROL TARTRATE
- Active ingredients
- LEVALBUTEROL TARTRATE
- Dosage form
- AEROSOL, METERED
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- LUPIN
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- First approval
- 2005-03-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown